[Embovin efficacy and tolerance in the treatment of patients with intestinal nematode infections].
The efficacy and tolerance of embovin, a new anthelminthic manufactured in Russia, was studied in 60 patients with nematodiases. The results evidence its high efficacy in ankylostomiasis (100%), enterobiasis (100%), and ascariasis (90 +/- 6.4%). The drug was well tolerated in all the cases. No adverse effects on the liver, pancreas, kidneys, as well as on the peripheral blood and urine composition were detected. This recommends embovin for wide use in medical practice.